Загрузка...
Immune checkpoint blockade in malignant mesothelioma: A novel therapeutic strategy against a deadly disease?
Monoclonal antibodies that target immune checkpoints are undoubtedly changing the therapeutic landscape of different human malignancies. Here we comment on the effects of blocking cytotoxic T lymphocyte-associated protein 4 (CTLA4) by means of the monoclonal antibody tremelimumab in patients with re...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Landes Bioscience
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3984267/ https://ncbi.nlm.nih.gov/pubmed/24734215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27482 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|